OBESE PATIENTS (BMI ≥ 30 KG/M²)
Clinical trials for OBESE PATIENTS (BMI ≥ 30 KG/M²) explained in plain language.
Never miss a new study
Get alerted when new OBESE PATIENTS (BMI ≥ 30 KG/M²) trials appear
Sign up with your email to follow new studies for OBESE PATIENTS (BMI ≥ 30 KG/M²), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New dosing method aims to cut bleeding risk in obese heart surgery patients
Disease control CompletedThis study tested a new way to calculate the dose of the blood-thinner heparin for obese patients during heart surgery using a heart-lung machine. Researchers compared dosing based on a patient's ideal body weight versus their total weight to see if it prevented excessive blood t…
Matched conditions: OBESE PATIENTS (BMI ≥ 30 KG/M²)
Phase: PHASE4 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Your genes may hold the key to which diabetes drug works best
Knowledge-focused CompletedThis study aimed to understand why some people respond better than others to certain diabetes medications. Researchers followed 260 obese adults with newly diagnosed Type 2 diabetes for six months, giving them either empagliflozin, dapagliflozin, or standard care. The main goal w…
Matched conditions: OBESE PATIENTS (BMI ≥ 30 KG/M²)
Phase: PHASE4 • Sponsor: Erbil Polytechnic University • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:41 UTC